Sean Grant
Equibles does not estimate personal net worth.
Get an email with a short summary when Vera Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get VERA alertsAbout Sean Grant
Sean Grant is recorded as CFO at Vera Therapeutics, Inc. (VERA). The newest filing on record that lists Sean Grant as CFO at Vera Therapeutics, Inc. (VERA) is dated April 9, 2026. The proxy statement of Vera Therapeutics, Inc. reports total compensation of $2,716,732 for Sean Grant in fiscal 2025, including a base salary of $507,000. Disclosed compensation is on record for 5 fiscal years. Vera Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vera Therapeutics, Inc. includes Marshall Fordyce (CEO and Board Member), Michael M. Morrissey, Ph.D. (Chairman and Board Member), Sean P. Grant (CFO) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 9, 2026
Company network
Leadership on record at Vera Therapeutics, Inc.
- Marshall Fordyce CEO, Board Member
- Michael M. Morrissey, Ph.D. Chairman, Board Member
- Sean P. Grant CFO
- David Johnson COO
- Andrew Cheng Board Member
- Beth Seidenberg Board Member
- Christopher Hite Board Member
- Christy Oliger Board Member
- James R. Meyers Board Member
- Kimball Hall Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Vera Therapeutics, Inc. (VERA) | Chief Financial Officer | $507,000 | $2,716,732 |
| 2023 | Vera Therapeutics, Inc. (VERA) | Chief Financial Officer | $455,000 | $1,761,820 |
| 2022 | Vera Therapeutics, Inc. (VERA) | Chief Financial Officer | $417,500 | $2,475,143 |
| 2021 | Vera Therapeutics, Inc. (VERA) | Chief Financial Officer | $189,487 | $2,082,371 |
| 2020 | Vera Therapeutics, Inc. (VERA) | Chief Financial Officer | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.